In late August, President Trump announced that the Food and Drug Administration (FDA) completed the authorization process for convalescent plasma treatment to aid victims of the coronavirus pandemic. The COVID-19 plasma treatment was previously available to many Americans, yet the FDA’s authorization will make the treatment more accessible to a […]